Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
GALECTIN RG (NQ: GALT)
3.460 USD  -0.210 (-5.72%)
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 282,313
Open 3.640
Bid (Size) 3.060 (2500)
Ask (Size) 3.710 (400)
Prev. Close 3.670
Today's Range 3.440 - 3.720
52wk Range 1.280 - 6.740
Shares Outstanding 34,670,684
Dividend Yield N/A
Performance
YTD
-10.36%
-10.36%
1 Month
-26.85%
-26.85%
3 Month
-33.72%
-33.72%
6 Month
+36.22%
+36.22%
1 Year
+11.97%
+11.97%
Top News
More News
Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’s CEO and CMO, has been selected... Read More
from GlobeNewswire News Releases
This Morning's Technical Outlook on Generic Drugs Stocks -- Fibrocell Science, Galectin Therapeutics, Lannett, and Mallinckrodt
from PR Newswire
More News
Read More
Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis
from GlobeNewswire News Releases
Galectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018
from GlobeNewswire News Releases
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
from GlobeNewswire News Releases
These Biotech Stocks Have a Strong Green Close on Friday
from ACCESSWIRE
Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update
from GlobeNewswire News Releases
Galectin Therapeutics to Present at Two International Conferences in March
from GlobeNewswire News Releases
8 Biotech Stocks With Clinical Trial Outcomes In April
category BPMC , SELB , Trading Ideas , and 11 more.
from Benzinga
Groestlcoin ($GRS): A Multi-Purpose, Private Cryptocurrency with Sub-Atomic Fees
from NetworkNewsWire
Mid-Afternoon Market Update: NASDAQ Up 2%; Movado Shares Surge On Earnings Beat
category Markets , Mid/Afternoon Market Update , Benzinga , and 14 more.
from Benzinga
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial